GlassScriptPhysician profile
Riley Spears
NPI 1568131175
$1,741.05
in general payments reported to CMS, 2019-2025
16 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.28 · 2023: $36.99 · 2024: $610 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,724.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $361.11 | 2025 | |
| Kerecis Limited | $272.40 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Intuitive Surgical, INC. | $252.81 | 2024-2025 | |
| Atricure, INC. | $173.97 | 2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Silk Road Medical, INC. | $113.87 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Getinge USA Sales, LLC | $103.24 | 2024-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Edwards Lifesciences Corporation | $94.52 | 2024 | Evoque |
| Lemaitre Vascular, INC. | $69.21 | 2025 | Artegraft Vascular Graft, Restoreflow, Hydro Lemaitre Valvulotome |
| Baxter Healthcare | $59.14 | 2025 | Preveleak, Perclot |
| Kls-Martin L.P. | $53.68 | 2021-2024 | |
| Ethicon US, LLC | $52.57 | 2023-2025 | Prolene |
| Solventum Corporation | $52.03 | 2024 | Activ.A.C. |
| Davol INC. | $26.08 | 2025 | Arista |
| On Target Laboratories, INC | $24.22 | 2025 | Cytalux |
| Teleflex LLC | $19.04 | 2024 | Manta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lightbody Medical Technologies INC | $13.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riley Spears listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.